Picard Medical, Inc.
corporate_fare Company Profile
Picard Medical, Inc. (NYSE:PMI) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 4 items for PMI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 9/10. Across its 4 most recent items scored 7 or higher, the top rating is 9/10, with 1 rated 8 or above. Recent SEC coverage for PMI spans 10-Q, S-3/A, PRE 14A, 8-K.
Recent high-impact activity:
- Picard Medical Q3: Going-Concern Warning With $67K Cash and Zero Product Revenue
- Picard Registers Resale of 500,000 Shares Tied to $1.0M Convertible Notes
- Picard Medical Seeks Votes on $5M Private Placement and Expanded Equity Plan
- Picard Medical Names Richard Fang Permanent CEO; Discloses $1.2M in Related-Party Loans
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 74,420 shares in PMI as of the October 30, 2026 settlement, a 44.9% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 46.1% of PMI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for PMI, detected from its recent SEC filings · based on capital-structure filings through 2026-11-10.
Resale Prospectus Filed for 500,000 Shares · No Company Proceeds From Resales
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →